Aspirin is an integral component in the secondary prevention of cardiovascular disease by inhibiting the irreversible activity of platelet cyclooxygenase-1, which prevents the production of the potent pro-aggregatory thromboxane A2. Here, PTGS1 is linked to cardiovascular disorder.